David Liebowitz, MD, PhD

Vaxart
San Francisco, CA
USA Papers:
OR.73 Mucosal Immune Responses Following Radio Controlled Capsule Delivery to Human Intestines - An Open Label Clinical Trial of An Influenza Vaccine Based on Recombinant Adenovirus